Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Wednesday, October 13, 1999 Published at 18:01 GMT 19:01 UK


Sci/Tech

Backlash for GM dissenters

GM soya as good as conventional soya, says Derek Burke

Claims that the system used to assess the safety of genetically-modified (GM) food is flawed has sparked a furious row among scientists.

Science policy researchers argued a week ago that GM foods should be subject to the same rigorous tests as pharmaceutical products.

They wrote in the journal Nature that the principle of "substantial equivalence", by which GM foods are assumed to be safe if they are chemically similar to their natural counterparts was "misguided" and unscientific.


Listen to the debate Dr Erik Millstone and Dr Peter Kearns had when the original Nature commentary was published
Erik Millstone, from the University of Sussex, Brighton, public health expert Eric Brunner, from University College London, and Sue Mayer, from the pressure group GeneWatch UK, said the principle was "a commercial and political judgement" that benefited manufacturers rather than consumers.

The reaction to their comments has been fast and furious with the latest edition of Nature carrying three hard-hitting replies.

Molecular biologist Anthony Trewavas, from the University of Edinburgh, and plant scientist Chris Leaver from the University of Oxford, accused the three authors of using "ill-informed logic" to obstruct the acceptance of new technology.

Food under the microscope
They wrote: "Their arguments are a distraction from the task of developing a sustainable and environmentally friendly agriculture, which combines the best of conventional plant breeding approaches with the new technologies."

If their advice was followed, said Trewavas and Leaver, "we would be drowning in toxicity tests".

Derek Burke, former chairman of the UK advisory committee on novel foods and processes, said data not cited by the three researchers had demonstrated GM soya beans were as safe as conventional soya beans. He called their arguments outdated, misleading and inaccurate.

He said their suggestion that an international conspiracy was trying to foist GM foods on a gullible public was "beyond belief", and wondered how such a "mish-mash of old hat sociology and poor science" had got published in Nature.

Peter Kearns, from the Organisation for Economic Co-operation and Development in Paris and Paul Mayers, from Health Canada in Ottawa, Ontario, who helped develop the idea of substantial equivalence, denied that the concept was created as an excuse for not requiring biochemical or toxicological tests.

They pointed out that it was devised before any new GM foods came on to the market by experts who spent more than two years discussing the safety issue.

It was not a substitute for safety assessment but a "guiding principle which is a useful tool for regulatory scientists engaged in safety assessments".





Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Sci/Tech Contents


Relevant Stories

06 Oct 99 | Sci/Tech
Call for tougher GM tests

14 Oct 99 | Sci/Tech
Greenpeace and Monsanto spell out GM creeds

05 Oct 99 | Sci/Tech
Terminator gene halt a 'major U-turn'

28 Sep 99 | Sci/Tech
Scientists unveil plastic plants

26 Sep 99 | The Company File
Monsanto bows to pressure

14 Oct 99 | Sheffield 99
GM viruses to turn plants into factories

26 Aug 99 | Sci/Tech
'GM crop can help environment'

14 Oct 99 | Sci/Tech
GM pollen 'can kill butterflies'





Internet Links


Nature

GeneWatch UK

Monsanto UK

GM Issues


The BBC is not responsible for the content of external internet sites.




In this section

World's smallest transistor

Scientists join forces to study Arctic ozone

Mathematicians crack big puzzle

From Business
The growing threat of internet fraud

Who watches the pilots?

From Health
Cold 'cure' comes one step closer